In Vivo Activity of MiR-34a Mimics Delivered by Stable Nucleic Acid Lipid Particles (SNALPs) against Multiple Myeloma
Maria Teresa Di Martino(Centro Clinico Nemo), Michele Caraglia(University of Campania "Luigi Vanvitelli")
Cited by 115
Related Papers
Emerging anti-cancer molecular mechanisms of aminobisphosphonates
|Endocrine Related Cancer|2006|131
Panobinostat synergizes with zoledronic acid in prostate cancer and multiple myeloma models by increasing ROS and modulating mevalonate and p38-MAPK pathways
|Cell Death and Disease|2013|57
Evidence of novel miR-34a-based therapeutic approaches for multiple myeloma treatment
|Scientific Reports|2017|49
miR-125b Upregulates miR-34a and Sequentially Activates Stress Adaption and Cell Death Mechanisms in Multiple Myeloma
|Molecular Therapy — Nucleic Acids|2019|41